etanidazole has been researched along with Lymphoma, T-Cell in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palayoor, ST | 1 |
| Bump, EA | 1 |
| Malaker, K | 1 |
| Langley, RE | 1 |
| Saroff, DM | 1 |
| Delfs, JR | 1 |
| Hurwitz, SJ | 1 |
| Coleman, CN | 1 |
1 other study available for etanidazole and Lymphoma, T-Cell
| Article | Year |
|---|---|
Modification of the aerobic cytotoxicity of etanidazole.
Topics: Aerobiosis; Animals; Apoptosis; Calcium; Cell Survival; Etanidazole; Lymphoma, T-Cell; Mice; Superox | 1994 |